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Pathogenesis
Adenocarcinoma is the most common malignancy of the stomach, accounting for nearly 90% of gastric tumors [7] . Pathologically, there are two types of gastric adenocarcinoma based upon location: cardia, or proximal, and distal, noncardia adenocarcinomas. These should be considered as separate entities because of differing epidemiologic relationships, associated risk factors, and prognosis [8] (Table 1 .1). Historically, distal gastric carcinoma was the most common type. However, because the rate of cardia tumors continues to increase while that of distal gastric cancers decreases [9, 10] , the incidence of proximal adenocarcinoma has surpassed that of distal cancers in recent years. This is an unfortunate change in the epidemiology of the disease since cancers of the gastric cardia generally have worse prognosis than distal gastric cancers [7, 10] .
Histologically, gastric cancer is divided into two main types: well-differentiated, intestinal type, and undifferentiated, diffuse type [8] . The latter occurs in the setting of diffuse gastritis without atrophy. This histologic type is seen throughout the world, whereas the intestinal type occurs in areas with a high incidence of gastric cancer and follows a predictable stepwise progression of cancer development from metaplasia.
In 1994, the International Agency for Research on Cancer and The World Health Organization classified Helicobacter pylori (Figure 1 .5) as a type I carcinogen, but toward malignancy, similar to that in the colon. In the Correa model of gastric carcinogenesis, gastric inflammation leads to mucosal atrophy, metaplasia, dysplasia, and, ultimately, carcinoma [11] . Studies have shown that H. pylori infection is an independent risk factor for distal gastric cancer, with a 3-to 6-fold increased risk relative to those without the infection [12, 13, 14] . However, the great majority of infected individuals will never develop gastric neoplasia: approximately 40% of patients infected with H. pylori will develop gastric metaplasia but fewer than 1% will develop cancer [15] .
Gastric atrophy also increases susceptibility of the cells to carcinogens. In patients with H. pylori, the presence of specific gene polymorphisms increases the risk of developing gastric carcinoma. Genes that encode tumor necrosis factor alpha (TNF-α), and interleukins IL-1, IL-8, and IL-10 have each been associated with higher cancer rates in the setting of H. pylori [16, 17] . While intestinal gastric cancer is strongly associated with chronic H. pylori, this strong link is not seen in diffuse gastric cancer. Diffuse or cardia gastric cancer, however, has been associated with other risk factors such as higher socioeconomic class [18] , obesity [19, 20] , and type A blood [21] .
Risk factors
The risk factors for gastric cancer are protean and detailed in Table 1 .2.
Ethnic and geographic factors
There is a higher incidence of gastric cancer in non-Caucasian populations. In the United States, the highest incidence is found in the Native American (21.6/100 000) and Asian (20/100 000) populations. Both race and sex affect the risk of disease development and subsequent mortality rate. The highest mortality rate based upon ethnic/sex combination is African-American males (12.4/100 000) [4] . However, there are similar overall 5-year survival rates among the different races.
The incidence of gastric carcinoma also varies dramatically by geographic location. In contrast to the American population, the societal burden of gastric cancer is much higher in Japan where it is the most common tumor type, accounting for approximately 19% of new tumor diagnoses based upon 2001 cancer registry data [22] . In Japanese men, the incidence rate is 116/100 000 [22] . A study by the American Cancer Society suggests that Japanese patients living within the United States who develop gastric cancer may even have differences in pathophysiology compared with their Caucasian counterparts. The percentage of cardia tumors in Japanese patients (11%) was less than half the percentage for the overall population in the study (28%) [5] . The study also showed that although gastric cancer is still more common in Japanese men than women, there was a smaller difference in the male-to-female ratio for Japanese patients compared with other Americans.
The rate of gastric cancer in other Asian countries such as Korea and China is also high. It is interesting to note that in similar parts of the world, incidence rates of gastric cancer can vary significantly. For example, within the European Union the highest mortality rate is found in Iceland and the lowest mortality rate is in Poland [23] . The mortality differs by the severity of disease at the time of diagnosis, and there is generally delayed diagnosis in Western populations as compared to in Japan. Still, there has been a long-term worldwide decrease in both the incidence and mortality associated with gastric cancer [24] .
Genetics
There are a variety of genes that increase the risk of gastric cancer that are detailed in Table 1 .3 and Figure 1 .6. Specific genes such as MCC, APC, and p53 tumor suppressor genes have been identified in a large percentage of gastric cancers [25] . Several studies have identified E-cadherin, a calcium-dependent adhesion molecule that is responsible for cellular binding to adjacent cells, as an important component in the gastric carcinogenesis cascade [26, 27, 28] . Genetic susceptibility involves hereditary transmission of a single mutated CDH1 allele. If there is an acquired mutation of the second allele in the E-cadherin gene, then loss of intracellular adhesion leads to increased intracellular permeability [29] . A wide variety of mutations in this domain have been identified in gastric cancer families [30] .
Multiple syndromes are associated with gastric carcinoma; most are associated with gastrointestinal polyp formation and have increased risk of cancer at other sites as well. These include familial adenomatous polyposis (FAP) and Cowden disease. The FAP genetic defect is located in the APC gene involved in the Wnt tumor-signaling pathway. This gene is located on chromosome 5q and involves development of different tumor types, including colonic and gastric cancers [31] .
In FAP a significant proportion of adenomatous polyps in the stomach will develop into carcinoma. Hamartomatous polyps, such as are found in Peutz-Jeghers disease and juvenile polyposis, have exceedingly low malignant potential. However, patients with these syndromes tend also to have an increased incidence of adenomatous polyps, which do carry the risk of malignant transformation.
Hereditary diffuse gastric carcinoma is an autosomal dominant trait on chromosome 16p22 and has an associated 67%-83% lifetime risk of gastric carcinoma [32] . Families are identified if there are two first-or second-degree relatives who develop gastric cancer before age 50 or if there are three such relatives regardless of age. Due to the high risk of malignancy, genetic screening of patients' families is recommended if a patient is diagnosed with diffuse cancer before age 35, if the patient is diagnosed with gastric and breast carcinoma, or if family members have both diffuse gastric cancer and breast cancer [29] .
In the absence of a defined familial syndrome, increased risk of gastric cancer is present in relatives of patients with breast cancer [33] . Also, the Li-Fraumeni syndrome has an increased risk of breast and gastric cancer in addition to more commonly seen melanoma, leukemia, brain tumors, and sarcomas. The syndrome is autosomal dominant in inheritance and demonstrates high penetrance in the cancer predisposition. This cancer risk is associated with mutations involving tumor suppressor genes, specifically germline TP53 mutations [34] .
Hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome II) is a risk factor for stomach cancer. In nearly one-quarter of these patients with gastric cancer, chromosomal mutations result in microsatellite instability [35] . In this syndrome, there is an approximately 4-fold increase in stomach cancer relative to the general population [36] . The disease is transmitted in an autosomal dominant pattern and has a high degree of penetrance [37] . Patients with Lynch syndrome II more typically present with early onset of colorectal cancer, and patients are also at increased risk of uterine carcinoma [38] . 
